| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 09/19/2007 | CN101039690A Enzyme inhibitors and uses thereof |
| 09/19/2007 | CN101039678A Imidazo[1,5a]triazolo[1,5d]benzodiazepine derivatives for the treatment of cognitive disorders |
| 09/19/2007 | CN101039675A Tetrodotoxin and its derivatives for the treatment of peripheral-nervously derived neuropathic pain |
| 09/19/2007 | CN101039674A Tetrodotoxin and its derivatives for the treatment of central-nervously derived neuropathic pain |
| 09/19/2007 | CN101039667A Treatment of bipolar disorders and associated symptoms |
| 09/19/2007 | CN101039666A 3-arylthioindole-2-carboxamide derivatives and analogs thereof as inhibitors of casein kinase i |
| 09/19/2007 | CN101039664A Atmosphere alteration method, and air spray and spray device used therefor |
| 09/19/2007 | CN101037438A Compositions useful as inhibitors of GSK-3 |
| 09/19/2007 | CN101037436A L-stepholidine (l-SPD) derivatives, preparation method and usage thereof |
| 09/19/2007 | CN101037430A (-)-meptazinol double-ligand derivative and/or its salt and preparation method and usage |
| 09/19/2007 | CN101036773A Application of compound agent in the medicine for treating fracture, tracheitis and depression for human beings |
| 09/19/2007 | CN101036768A Traditional Chinese medicine for treating senile dementia and preparation process thereof |
| 09/19/2007 | CN101036760A Composition having stomachic, liver-care, and hypermnesia functions and the preparing technique |
| 09/19/2007 | CN101036759A Novel function of highland barley extractive |
| 09/19/2007 | CN101036669A Application of Li2WO4 in preparing medicine |
| 09/19/2007 | CN101036639A Application of piperlonguminine and dihydropiperlonguminine in the preparation of the medicine for curing senile dementia |
| 09/19/2007 | CN101036525A Antialcoholism and thirst-quenching functional drink and the technique for preparing the same |
| 09/19/2007 | CN100338062C Azaindoles as inhibitors of c-Jun N-terminal kinases |
| 09/19/2007 | CN100338061C Alkyne-aryl phosphodiesterase-4 inhibitors |
| 09/19/2007 | CN100338060C Novel use of substituted aminomethyl chromans |
| 09/19/2007 | CN100338058C 新的吲哚衍生物 The new indole derivatives |
| 09/19/2007 | CN100338055C Carbamates of 2-heterocyclic-1, 2-ethanediols |
| 09/19/2007 | CN100338051C Method for preparation of citalopram |
| 09/19/2007 | CN100338042C Triazole derivatives as cyclooxygenase (COX) inhibitors |
| 09/19/2007 | CN100338038C New brand of Aripipazole, and preparation method |
| 09/19/2007 | CN100338028C Crystalline forms of venlafaxine hydrochloride |
| 09/19/2007 | CN100337687C Gamma-aminobutyric acid derivatives containing, solid compositions and process for preparing the same |
| 09/19/2007 | CN100337680C Compsn. of edinebriating capsule and preparing method |
| 09/19/2007 | CN100337679C Chinese traditional medicine capable of invigorating yang and strengthening qi and its preparation |
| 09/19/2007 | CN100337668C Chinese medicinal powder for treating Bell's palsy |
| 09/19/2007 | CN100337661C Application of ampelopsis plant and its extract in preparing medicine and health article |
| 09/19/2007 | CN100337628C Nimodipine oral disintegrant tablet for curing dementia and its preparation method |
| 09/19/2007 | CN100337626C Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals |
| 09/19/2007 | CN100337613C Effervescence particles and preparing method thereof |
| 09/19/2007 | CN100337560C Sobering tea and its prepn. method |
| 09/18/2007 | USRE39847 Method of treating a systemic disease |
| 09/18/2007 | US7271289 4'-(azetidin-1-ylcarbonyl)-N-cyclopropyl-5-fluoro-6-methyl-1,1'-biphenyl-3-carboxamide; enzyme inhibitors for the treatment of certain diseases and conditions; chemical synthesis |
| 09/18/2007 | US7271266 Sucha as methyl 2-(benzyloxy)-6-(4-chlorophenyl)-5-(phenyl)pyridine-3-carboxylate; For therapy and prophylaxis of psychosis, memory deficits, cognitive disorders, migraine, neuropathy, neuro-inflammatory disorders including multiple sclerosis and Guillain-Barre syndrome, stress, epilepsy |
| 09/18/2007 | US7271260 3,4-dihydroquinazoline derivatives as T-type calcium channel blockers and method of preparing the same |
| 09/18/2007 | US7271197 prophylaxis and treatment of respiratory diseases; compounds having potent and selective stimulant action at beta 2-adrenoreceptors and having an advantageous profile of action |
| 09/18/2007 | US7271194 Treatment of neurotic disorders |
| 09/18/2007 | US7271192 Nitrogen oxide synthase inhibitors; synthesis |
| 09/18/2007 | US7271191 Pyrazole derivatives as gamma-secretase inhibitors useful in the treatment of Alzheimer's disease |
| 09/18/2007 | US7271190 Indazole compounds as β3 adrenoceptor agonist |
| 09/18/2007 | US7271181 Inhibitors of p38 |
| 09/18/2007 | US7271170 Imidazo-pyrimidines and triazolo-pyrimidines: benzodiazepine receptor ligands |
| 09/18/2007 | US7271168 Piperazine derivatives having SST1 antagonistic activity |
| 09/18/2007 | US7271164 Therapy , prevention of obsessive-complusive disorders; antidepressants; anxiety; schizophrenia; eating disorders; obesity; antiepileptic agents central nervous system disorders; sleep disorders |
| 09/18/2007 | US7271163 Cyclopenta[b][1,4]diazepino[6,7,1-hi]indoles and derivatives |
| 09/18/2007 | US7271162 Cycloocta[b][1,4]diazepino[6,7,1-hi]indoles and derivatives |
| 09/18/2007 | US7271156 Immunostimulatory nucleic acids |
| 09/18/2007 | US7270999 Clock gene BMAL2 |
| 09/18/2007 | US7270962 Screening for agonist or antagonist to axon outgrowth inhibitors for use in prevention and designing treatments for brain, stroke and spinal injured individuals |
| 09/18/2007 | US7270839 Process of obtaining thylakoids from photosynthetic organisms; plant fractions obtained from the process; pure thylakoids; and methods of use of thylakoids as ROS scavengers, photo-protectors, biosensors, biofilters and bioreactors |
| 09/18/2007 | US7270818 Treating brain disorder by administering a therapeutically effective amount of antisense oligonucleotide; preventing the formation of Alzheimer senile plaques |
| 09/18/2007 | US7270815 2-O sulfatase compositions and related methods |
| 09/18/2007 | CA2418267C Method of screening ptp zeta activity promoter or inhibitor |
| 09/18/2007 | CA2417106C Piperazine derivatives |
| 09/18/2007 | CA2329077C Pyrazolopyrimidinone cgmp pde5 inhibitors for the treatment of sexual dysfunction |
| 09/18/2007 | CA2299586C Human glial cell line-derived neurotrophic factor promoters, vectors containing same, and methods of screening compounds therewith |
| 09/18/2007 | CA2287991C New benzylamine derivatives and phenylethylamine derivatives, process for preparing them and their use as medicaments |
| 09/18/2007 | CA2269698C Agent for treating neurodegenerative disorders |
| 09/18/2007 | CA2243234C 5h-thiazolo[3,2-a]pyrimidine derivatives |
| 09/18/2007 | CA2221771C Use of tropolone derivatives as inhibitors of the enzyme inositol monophosphatase |
| 09/18/2007 | CA2211982C Substituted indanylidineacetylguanidines, process for their preparation,their use as medicaments or diagnostic and medicaments containing them |
| 09/18/2007 | CA2095797C Arylacetamides |
| 09/13/2007 | WO2007104030A1 Retinoids and related compounds for the treatment of neuroinflammatory conditions, diseases and disorders |
| 09/13/2007 | WO2007103554A1 Quinoline and isoquinoline derivatives as phosphodiesterase 10 inhibitors |
| 09/13/2007 | WO2007103347A1 Meridamycin analogues for the treatment of neurodegenerative disorders |
| 09/13/2007 | WO2007103260A1 Phosphodiesterase 10 inhibitors |
| 09/13/2007 | WO2007103221A2 An improved process for the preparation of armodafinil |
| 09/13/2007 | WO2007102703A1 Composition for prevention or treatment of diseases in central nervous system comprising extract of cimicifuga heracleifolia komarow |
| 09/13/2007 | WO2007102660A1 Vanilloid receptor antagonist for prevention and treatment of drug dependence and addiction |
| 09/13/2007 | WO2007102580A1 Polycyclic cinnamide derivative |
| 09/13/2007 | WO2007102571A1 Therapeutic agent for functional brain disease |
| 09/13/2007 | WO2007102531A1 Pharmaceutical combination |
| 09/13/2007 | WO2007102515A1 Phenylthiazole derivative |
| 09/13/2007 | WO2007102058A1 Alpha-2-delta ligands for non-restorative sleep |
| 09/13/2007 | WO2007101991A1 Target for the enhancement qf cognitive function |
| 09/13/2007 | WO2007101802A1 4-amino-1,5-substituted 1,5-dihydro-imidazol-2-ones |
| 09/13/2007 | WO2007101400A1 Transdermal patch containing rasagiline for treatment or prophylaxis of nervous system disease and its preparation process |
| 09/13/2007 | WO2007101353A1 A cyclohexane polyalcohol formulation for treatment of disorders of protein aggregation |
| 09/13/2007 | WO2007084841A3 Sulfonyl substituted 1h-indoles as ligands for the 5-hydroxytryptamine receptors |
| 09/13/2007 | WO2007083146A3 The treatment of cognitive and psychotic disorders |
| 09/13/2007 | WO2007082208A3 Lanthionine-related compounds for the treatment of inflammatory diseases |
| 09/13/2007 | WO2007079977A3 Nutraceutical compositions comprising tripeptides |
| 09/13/2007 | WO2007079840A3 Benzochromene derivatives |
| 09/13/2007 | WO2007073702A3 Multi-layered tablet with triple release combination |
| 09/13/2007 | WO2007071055A8 Compositions and methods for modulating gated ion channels |
| 09/13/2007 | WO2007063391A3 Spirocyclic quinazoline derivatives as pde7 inhibitors |
| 09/13/2007 | WO2007060140A3 Inhibitors of diacyglycerol acyltransferase (dgat) |
| 09/13/2007 | WO2007051333A8 Triazine beta-secretase inhibitors |
| 09/13/2007 | WO2006138418A3 Improvement of cognitive performance with sirtuin activators |
| 09/13/2007 | WO2006024627A3 N-2 adamantanyl-2-phenoxy-acetamide derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 09/13/2007 | WO2006002846A3 New analogs of nitrobenzylthioinosine |
| 09/13/2007 | US20070213684 Methods and apparatuses for assuring quality and safety of drug administration and medical products and kits |
| 09/13/2007 | US20070213401 Pharmaceutical uses for alpha2delta ligands |
| 09/13/2007 | US20070213394 Salvinorin derivatives and uses thereof |
| 09/13/2007 | US20070213387 Such as 3-[2-[3-(dimethylamino)-2-hydroxypropoxy]phenyl]-4-(1-ethenyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione; protein kinase C inhibitors; for treatment of diabetes |
| 09/13/2007 | US20070213386 protein kinase C or glycogen synthase kinase-3-beta inhibitors such as 3-[2-[3-(dimethylamino)-2-hydroxypropoxy]phenyl]-4-(1-ethenyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione, used for treating diabetes, dementias such as Alzheimer's disease and bipolar disorders |